Again, although these GSEA analyses do not prove causality, they are consistent with a role for the AHR in regulation of invasion-associated genes and suggest that AHR inhibition would be a useful strategy for breast cancer therapy as suggested for other cancer types [13]. The gene discussed is AHR; the disease is breast carcinoma.